Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.59% | -3.03% | -2.99% | -1.53% | 2.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.59% | -3.03% | -2.99% | -1.53% | 2.68% |
| Cost of Revenue | 1.18% | -2.32% | -3.34% | -1.30% | 2.33% |
| Gross Profit | -4.22% | -3.33% | -2.85% | -1.62% | 2.84% |
| SG&A Expenses | -5.65% | 5.78% | -4.24% | -7.78% | 1.15% |
| Depreciation & Amortization | -10.24% | -8.20% | -5.02% | 27.96% | 40.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.38% | -1.13% | -5.27% | -2.78% | 4.46% |
| Operating Income | 28.72% | -40.90% | 30.99% | 16.67% | -22.23% |
| Income Before Tax | -40.49% | -89.84% | 45.44% | -1,160.85% | -15.54% |
| Income Tax Expenses | -778.62% | -93.23% | 131.40% | 507.98% | 295.01% |
| Earnings from Continuing Operations | -13.58% | -67.56% | 41.70% | -1,185.22% | -18.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.58% | -67.56% | 41.70% | -1,185.22% | -18.29% |
| EBIT | 28.72% | -40.90% | 30.99% | 16.67% | -22.23% |
| EBITDA | 10.91% | -73.01% | 1.70% | 600.57% | -1.89% |
| EPS Basic | -9.40% | -61.03% | 43.87% | -1,139.50% | -14.90% |
| Normalized Basic EPS | 36.52% | -133.95% | 48.61% | 24.59% | -13.08% |
| EPS Diluted | -9.40% | -61.03% | 43.87% | -1,139.50% | -14.90% |
| Normalized Diluted EPS | 36.52% | -133.95% | 48.61% | 24.59% | -13.08% |
| Average Basic Shares Outstanding | 3.83% | 4.04% | 3.86% | 3.69% | 2.95% |
| Average Diluted Shares Outstanding | 3.83% | 4.04% | 3.86% | 3.69% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |